Blood Pressure Targets for CKD Stage 5 Patients on Dialysis
For patients with CKD stage 5 on hemodialysis, target a pre-dialysis blood pressure of <140/90 mm Hg and post-dialysis blood pressure of <130/80 mm Hg. 1
Why These Targets Apply to Dialysis Patients
The KDIGO 2021 guideline explicitly states that its systolic blood pressure target of <120 mm Hg does not apply to patients receiving dialysis. 2 This exclusion is critical because:
- Dialysis patients were systematically excluded from SPRINT, the primary trial supporting the <120 mm Hg target 2
- The relationship between blood pressure and mortality in dialysis patients follows a U-shaped curve, where both very low (<120 mm Hg pre-dialysis) and very high (>180 mm Hg pre-dialysis) systolic pressures associate with increased mortality risk 1
- Applying aggressive targets risks catastrophic complications including hypoperfusion, acute kidney injury, falls, and fractures in this vulnerable population 3
Practical Implementation Considerations
Measurement timing matters critically in dialysis patients:
- Pre-dialysis measurements should be <140/90 mm Hg 1
- Post-dialysis measurements should be <130/80 mm Hg 1
- Out-of-dialysis center measurements predict left ventricular hypertrophy and mortality better than in-center measurements 1
These targets should only be pursued if the patient tolerates them without:
- Substantial orthostatic hypotension 1
- Significant symptomatic intradialytic hypotension 1
- Centers achieving better post-dialysis blood pressure control experience significantly more intradialytic hypotension requiring fluid resuscitation 4
Medication Selection
First-line therapy should be ACE inhibitors or ARBs because they provide:
- Greater regression of left ventricular hypertrophy 1
- Reduced sympathetic nervous system activity 1
- Decreased pulse wave velocity 1
- Possible improvement in endothelial function 1
Beta-blockers should be preferred in patients with:
Volume Management is Foundational
Blood pressure control in dialysis patients requires addressing volume status, not just medications:
- Continuous emphasis on salt restriction is integral to management 1
- Achieving dry weight and reducing extracellular volume should be pursued, though this is difficult to monitor and may not be effective in all patients 1
Common Pitfalls to Avoid
Never apply the <120 mm Hg target to dialysis patients - this population faces increased risks of adverse events and was explicitly excluded from supporting evidence 3
Avoid excessive diastolic blood pressure lowering (<70 mm Hg) - this increases cardiovascular risk in CKD patients 3
Do not ignore intradialytic hypotension - achieving tighter post-dialysis targets significantly increases symptomatic hypotension requiring intervention 4